Dye-free Childrens Loratadine Tablet, Chewable
NDC Package 51660-112-31
Package Information
Dye-free Childrens Loratadine (loratadine) tablets is chew or crush tablets completely before swallowing.adults and children 6 years and overchew 2 tablets daily; not more than 2 chewable tablets in 24 hourschildren 2 to under 6 years of agechew 1 tablet daily; not more than 1 chewable tablet in 24 hourschildren under 2 years of ageask a doctorconsumers with liver or kidney diseaseask a doctor. This formulation utilizes a tablet, chewable delivery system. Marketed by Ohm Laboratories Inc., this product is identified by NDC 51660-112 and is authorized under FDA application ANDA210088.
Identification & Billing
- RxCUI: 665078 - loratadine 5 MG 24HR Chewable Tablet
- RxCUI: 665078 - loratadine 5 MG Chewable Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51660 - Ohm Laboratories Inc.
- 51660-112 - Dye-free Childrens Loratadine
- 51660-112-31 - 3 BLISTER PACK in 1 CARTON / 10 TABLET, CHEWABLE in 1 BLISTER PACK
- 51660-112 - Dye-free Childrens Loratadine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51660-112-31 identifies a specific commercial package of 3 blister pack in 1 carton / 10 tablet, chewable in 1 blister pack of Dye-free Childrens Loratadine, a human over the counter drug labeled by Ohm Laboratories Inc.. This tablet, chewable is formulated for oral use and contains loratadine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Laboratories Inc. on August 19, 2020. The current certification is valid through December 31, 2026.
How is this Ohm Laboratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51660011231. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.